Patents by Inventor Ollivier Francis Nicolas Gavard

Ollivier Francis Nicolas Gavard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10669318
    Abstract: The present invention relates to a process for conjugation of an antigen.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: June 2, 2020
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Ralph Leon Biemans, Pierre Duvivier, Ollivier Francis Nicolas Gavard
  • Patent number: 9265840
    Abstract: Process for conjugation of bacterial saccharides including Streptococcus pneumoniae and Haemophilus influenzae saccharides by reductive amination are provided herein.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: February 23, 2016
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Ralph Leon Biemans, Pierre Duvivier, Ollivier Francis Nicolas Gavard
  • Patent number: 9265839
    Abstract: Process for conjugation of bacterial saccharides including Streptococcus pneumoniae and Haemophilus influenzae saccharides by reductive amination are provided herein.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: February 23, 2016
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Ralph Leon Biemans, Pierre Duvivier, Ollivier Francis Nicolas Gavard
  • Publication number: 20140186390
    Abstract: Process for conjugation of bacterial saccharides including Streptococcus pneumoniae and Haemophilus influenzae saccharides by reductive amination are provided herein.
    Type: Application
    Filed: March 10, 2014
    Publication date: July 3, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Ralph Leon BIEMANS, Pierre DUVIVIER, Ollivier Francis Nicolas GAVARD
  • Publication number: 20140186389
    Abstract: Process for conjugation of bacterial saccharides including Streptococcus pneumoniae and Haemophilus influenzae saccharides by reductive amination are provided herein.
    Type: Application
    Filed: March 10, 2014
    Publication date: July 3, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Ralph Leon BIEMANS, Pierre DUVIVIER, Ollivier Francis Nicolas GAVARD
  • Patent number: 8753645
    Abstract: Process for conjugation of bacterial saccharides including Streptococcus pneumoniae and Haemophilus influenzae saccharides by reductive amination are provided herein.
    Type: Grant
    Filed: March 7, 2011
    Date of Patent: June 17, 2014
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Ralph Leon Biemans, Pierre Duvivier, Ollivier Francis Nicolas Gavard
  • Publication number: 20120321658
    Abstract: The present invention relates to an immunogenic composition comprising at least 2 different S. pneumoniae capsular saccharides, wherein one or more is/are selected from a first group consisting of serotypes 1, 3, 19A and 19F which is/are linked to a protein carrier(s) either directly or indirectly through a chemistry other than reductive amination, and one or more different saccharides is/are selected from a second group consisting of serotypes 4, 5, 6A, 6B, 7F, 9V, 14, 18C and 23F which is/are linked to a protein carrier(s) by reductive amination. Uses of such compositions are also disclosed.
    Type: Application
    Filed: August 17, 2010
    Publication date: December 20, 2012
    Inventors: Ralph Leon Biemans, Pierre Duvivier, Ollivier Francis Nicolas Gavard, Jan Poolman
  • Publication number: 20120321660
    Abstract: Process for conjugation of bacterial saccharides including Streptococcus pneumoniae and Haemophilus influenzae saccharides by reductive amination are provided herein.
    Type: Application
    Filed: March 7, 2011
    Publication date: December 20, 2012
    Inventors: Ralph Leon Biemans, Pierre Duvivier, Ollivier Francis Nicolas Gavard